Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease (Q36143799)

12 August 2017

Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease (English)

1 reference

12 August 2017

1 reference

1 reference

Ashley J Hood

1

1 reference

12 August 2017

Silvia C Amador

2

1 reference

12 August 2017

Ashley E Cain

3

1 reference

12 August 2017

Kevin A Briand

4

1 reference

12 August 2017

Ali H Al-Refai

5

1 reference

12 August 2017

Mya C Schiess

6

1 reference

12 August 2017

Anne B Sereno

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

18 December 2006

1 reference

12 August 2017

6

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

inferred from page(s)

published in

1 reference

12 August 2017

78

1 reference

12 August 2017

565-570

1 reference

12 August 2017

6

1 reference

Saccadic latency distributions in Parkinson's disease and the effects of L-dopa

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Eye movement control by the cerebral cortex

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Using saccades as a research tool in the clinical neurosciences

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Functional organization of human intraparietal and frontal cortex for attending, looking, and pointing.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Disturbed striatoprefrontal mediated visual behaviour in moderate to severe parkinsonian patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Core assessment program for intracerebral transplantations (CAPIT)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Voluntary control of saccadic eye movements in patients with schizophrenic and affective disorders

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Control of saccades in Parkinson's disease.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Nicotine reduces antisaccade errors in task impaired schizophrenic subjects

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Altered control of visual fixation and saccadic eye movements in attention-deficit hyperactivity disorder.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Automatic orienting of visuospatial attention in Parkinson's disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Control of voluntary and reflexive saccades in Parkinson's disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Sequences of memory-guided saccades in Parkinson's disease.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Antisaccades and smooth pursuit eye movements in schizophrenia.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2077956

Dissociating cognitive deficits involved in voluntary eye movement dysfunctions in Parkinson's disease patients

23 September 2018

1 reference

12 December 2020

Self-initiated versus externally triggered movements

1 reference

12 December 2020

Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis

1 reference

12 December 2020

Spatial selective attention in schizophrenic, affective disorder, and normal subjects

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.2006.099754

1 reference

12 August 2017

1 reference

12 August 2017

1 reference